Optimal Use of 2',7'-Dichlorofluorescein Diacetate in Cultured Hepatocytes

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2022 May 3

PMID 35505044

Authors

Megan J Reiniers

Lianne R de Haan

Laurens F Reeskamp

Mans Broekgaarden

Ruurdtje Hoekstra

Rowan F van Golen

Michal Heger

Affiliations

Soon will be listed here.

Abstract

Oxidative stress is a state that arises when the production of reactive transients overwhelms the cell's capacity to neutralize the oxidants and radicals. This state often coincides with the pathogenesis and perpetuation of numerous chronic diseases. On the other hand, medical interventions such as radiation therapy and photodynamic therapy generate radicals to selectively damage and kill diseased tissue. As a result, the qualification and quantification of oxidative stress are of great interest to those studying disease mechanisms as well as therapeutic interventions. 2',7'-Dichlorodihydrofluorescein-diacetate (DCFH-DA) is one of the most widely used fluorogenic probes for the detection of reactive transients. The nonfluorescent DCFH-DA crosses the plasma membrane and is deacetylated by cytosolic esterases to 2',7'-dichlorodihydrofluorescein (DCFH). The nonfluorescent DCFH is subsequently oxidized by reactive transients to form the fluorescent 2',7'-dichlorofluorescein (DCF). The use of DCFH-DA in hepatocyte-derived cell lines is more challenging because of membrane transport proteins that interfere with probe uptake and retention, among several other reasons. Cancer cells share some of the physiological and biochemical features with hepatocytes, so probe-related technical issues are applicable to cultured malignant cells as well. This study therefore analyzed the in vitro properties of DCFH-DA in cultured human hepatocytes (HepG2 cells and differentiated and undifferentiated HepaRG cells) to identify methodological and technical features that could impair proper data analysis and interpretation. The main issues that were found and should therefore be accounted for in experimental design include the following: (1) both DCFH-DA and DCF are taken up rapidly, (2) DCF is poorly retained in the cytosol and exits the cell, (3) the rate of DCFH oxidation is cell type-specific, (4) DCF fluorescence intensity is pH-dependent at pH < 7, and (5) the stability of DCFH-DA in cell culture medium relies on medium composition. Based on the findings, the conditions for the use of DCFH-DA in hepatocyte cell lines were optimized. Finally, the optimized protocol was reduced to practice and DCFH-DA was applied to visualize and quantify oxidative stress in real time in HepG2 cells subjected to anoxia/reoxygenation as a source of reactive transients.

Citing Articles

Mechanisms of Arachidonic Acid In Vitro Tumoricidal Impact.

Tallima H, El Ridi R Molecules. 2023; 28(4).

PMID: 36838715 PMC: 9966399. DOI: 10.3390/molecules28041727.

Experimental Conditions That Influence the Utility of 2'7'-Dichlorodihydrofluorescein Diacetate (DCFH-DA) as a Fluorogenic Biosensor for Mitochondrial Redox Status.

de Haan L, Reiniers M, Reeskamp L, Belkouz A, Ao L, Cheng S Antioxidants (Basel). 2022; 11(8).

PMID: 35892626 PMC: 9329753. DOI: 10.3390/antiox11081424.

References

Reiniers M, van Golen R, van Gulik T, Heger M . Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver. Antioxid Redox Signal. 2013; 21(7):1119-42. PMC: 4123468. DOI: 10.1089/ars.2013.5486. View

Zangar R, Davydov D, Verma S . Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol. 2004; 199(3):316-31. DOI: 10.1016/j.taap.2004.01.018. View

F Turrens J . Mitochondrial formation of reactive oxygen species. J Physiol. 2003; 552(Pt 2):335-44. PMC: 2343396. DOI: 10.1113/jphysiol.2003.049478. View

Kakhlon O, Cabantchik Z . The labile iron pool: characterization, measurement, and participation in cellular processes(1). Free Radic Biol Med. 2002; 33(8):1037-46. DOI: 10.1016/s0891-5849(02)01006-7. View

Bedard K, Krause K . The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007; 87(1):245-313. DOI: 10.1152/physrev.00044.2005. View

Kloek J, Marechal X, Roelofsen J, Houtkooper R, van Kuilenburg A, Kulik W . Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion. Antioxid Redox Signal. 2012; 17(8):1109-23. DOI: 10.1089/ars.2011.4291. View

Weijer R, Broekgaarden M, van Golen R, Bulle E, Nieuwenhuis E, Jongejan A . Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells. BMC Cancer. 2015; 15:1014. PMC: 4691291. DOI: 10.1186/s12885-015-1994-2. View

Weijer R, Clavier S, Zaal E, Pijls M, van Kooten R, Vermaas K . Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy. Cell Mol Life Sci. 2016; 74(6):1133-1151. PMC: 5309296. DOI: 10.1007/s00018-016-2401-0. View

Weijer R, Broekgaarden M, Krekorian M, Alles L, van Wijk A, Mackaaij C . Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy. Oncotarget. 2015; 7(3):3341-56. PMC: 4823110. DOI: 10.18632/oncotarget.6490. View

10.

Broekgaarden M, de Kroon A, van Gulik T, Heger M . Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy. Curr Med Chem. 2013; 21(3):377-91. DOI: 10.2174/09298673113209990211. View

11.

Song C, Xu W, Wu H, Wang X, Gong Q, Liu C . Photodynamic therapy induces autophagy-mediated cell death in human colorectal cancer cells via activation of the ROS/JNK signaling pathway. Cell Death Dis. 2020; 11(10):938. PMC: 7603522. DOI: 10.1038/s41419-020-03136-y. View

12.

Liu C, Cao Y, Cheng Y, Wang D, Xu T, Su L . An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy. Nat Commun. 2020; 11(1):1735. PMC: 7142144. DOI: 10.1038/s41467-020-15591-4. View

13.

Zou H, Wang F, Zhou J, Liu X, He Q, Wang C . Application of photodynamic therapy for liver malignancies. J Gastrointest Oncol. 2020; 11(2):431-442. PMC: 7212095. DOI: 10.21037/jgo.2020.02.10. View

14.

Ogbodu R, Nitzsche B, Ma A, Atilla D, Gurek A, Hopfner M . Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer. J Photochem Photobiol B. 2020; 208:111915. DOI: 10.1016/j.jphotobiol.2020.111915. View

15.

Fadel M, Fadeel D, Ibrahim M, Hathout R, El-Kholy A . One-Step Synthesis of Polypyrrole-Coated Gold Nanoparticles for Use as a Photothermally Active Nano-System. Int J Nanomedicine. 2020; 15:2605-2615. PMC: 7173958. DOI: 10.2147/IJN.S250042. View

16.

Wardman P . Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects. Free Radic Biol Med. 2007; 43(7):995-1022. DOI: 10.1016/j.freeradbiomed.2007.06.026. View

17.

Gomes A, Fernandes E, Lima J . Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods. 2005; 65(2-3):45-80. DOI: 10.1016/j.jbbm.2005.10.003. View

18.

Wrona M, Patel K, Wardman P . Reactivity of 2',7'-dichlorodihydrofluorescein and dihydrorhodamine 123 and their oxidized forms toward carbonate, nitrogen dioxide, and hydroxyl radicals. Free Radic Biol Med. 2004; 38(2):262-70. DOI: 10.1016/j.freeradbiomed.2004.10.022. View

19.

Reiniers M, van Golen R, Bonnet S, Broekgaarden M, van Gulik T, Egmond M . Preparation and Practical Applications of 2',7'-Dichlorodihydrofluorescein in Redox Assays. Anal Chem. 2017; 89(7):3853-3857. PMC: 5382573. DOI: 10.1021/acs.analchem.7b00043. View

20.

Wrona M, Patel K, Wardman P . The roles of thiol-derived radicals in the use of 2',7'-dichlorodihydrofluorescein as a probe for oxidative stress. Free Radic Biol Med. 2007; 44(1):56-62. DOI: 10.1016/j.freeradbiomed.2007.09.005. View